SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients
16 references·0 citing·44 second hopsampled
Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients (2018)Systematic review of health state utility…Dreamtime: Version 5.0 of the Australian Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) (2017)Dreamtime: Version 5.0 of the…Health state utilities in non–small cell lung cancer: An international study (2016)Health state utilities in non…Systematic Searching and Selection of Health State Utility Values from the Literature (2013)Systematic Searching and Sele…Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting (2013)Health-Related Quality of Lif…Health outcomes in economic evaluation: the QALY and utilities (2010)Health outcomes in economic e…Derivation of Utility Values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 Questionnaire Values in Lung Cancer (2010)Derivation of Utility Values …A Review and Meta-Analysis of Utility Values for Lung Cancer (2010)A Review and Meta-Analysis of…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)Preferred reporting items for…Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for…Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred Reporting Items for…Health state utility scores in advanced non-small cell lung cancer (2008)Health state utility scores i…Health state utilities for non small cell lung cancer (2008)Health state utilities for no…The Estimation of a Preference-Based Measure of Health From the SF-12 (2004)The Estimation of a Preferenc…The estimation of a preference-based measure of health from the SF-36 (2002)The estimation of a preferenc…Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer (2001)Quality of Life and Utility i…Multiattribute Utility Function for a Comprehensive Health Status Classification System (1996)Multiattribute Utility Functi…A 12-Item Short-Form Health Survey (1996)Decision Making in Health and Medicine: Integrating Evidence and Values (2001)SF-36 health survey: Manual and interpretation guide (2003)Methods for the Economic Evaluation of Health Care Programmes (2005)US Norms for Six Generic Health-Related Quality-of-Life Indexes From the National Health Measurement Study (2007)Prevalence and Perceived Health Associated with Insomnia Based on DSM-IV-TR; International Statistical Classification of Diseases and Related Health Problems, Tenth Revision; and Research Diagnostic Criteria/International Classification of Sleep Disorders, Second Edition Criteria: Results from the America Insomnia Survey (2011)EuroQol - a new facility for the measurement of health-related quality of life (1990)Measuring Health-Related Quality of Life (1993)Modeling Valuations for EuroQol Health States (1997)Health state utilities in patients with advanced non-small-cell lung cancer in China (2018)Cost-effectiveness of Osimertinib as First-line Treatment and Sequential Therapy for EGFR Mutation-positive Non-small Cell Lung Cancer in China (2019)The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer (2022)Decisions with Multiple Objectives: Preferences and Value Tradeoffs. (1994)Determining Clinically Important Differences in Health Status Measures (1999)The Health Utilities Index (HUI®) system for assessing health-related quality of life in clinical studies (2001)Cost-Effectiveness Analysis Alongside Clinical Trials II—An ISPOR Good Research Practices Task Force Report (2015)Theory of games and economic behavior (2019)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration (2009)Rayyan—a web and mobile app for systematic reviews (2016)The PRISMA 2020 statement: an updated guideline for reporting systematic reviews (2021)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1956)The magical number seven, plus or minus two: Some limits on our capacity for processing information. (1994)Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force (2013)Health, Health-Related Quality of Life, and Quality of Life: What is the Difference? (2016)Valuing health-related quality of life: An EQ-5D-5L value set for England (2017)Measurement of health state utilities for economic appraisal (1986)Quality of life and pharmacoeconomics in clinical trials (1996)Variations in population health status: results from a United Kingdom national questionnaire survey (1998)Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients WithEGFR-Mutated Advanced Non–Small Cell Lung Cancer (2018)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration (2009)PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation (2018)A utility maximization model for evaluation of health care programs. (1972)Utility approach to measuring health-related quality of life (1987)First‐line atezolizumab in addition to bevacizumab plus chemotherapy for metastatic, nonsquamous non–small cell lung cancer: A United States–based cost‐effectiveness analysis (2019)Cost-Effectiveness Analysis of Durvalumab Plus Chemotherapy in the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (2021)Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations (2021)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement (2015)Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain (2013)A Health Opportunity Cost Threshold for Cost-Effectiveness Analysis in the United States (2020)An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations (2021)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement83,813 cited
  • 2009Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.44,857 cited
  • 2009Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement37,549 cited
  • 2002The estimation of a preference-based measure of health from the SF-363,031 cited
  • 2004The Estimation of a Preference-Based Measure of Health From the SF-121,293 cited
  • 2010Health outcomes in economic evaluation: the QALY and utilities1,122 cited
  • 1996Multiattribute Utility Function for a Comprehensive Health Status Classification System900 cited
  • 2008Health state utilities for non small cell lung cancer407 cited
  • 2016Health state utilities in non–small cell lung cancer: An international study304 cited
  • 2013Health-Related Quality of Life and Utility in Patients with Advanced Non–Small-Cell Lung Cancer: A Prospective Cross-Sectional Patient Survey in a Real-World Setting147 cited
  • 2001Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer117 cited
  • 2008Health state utility scores in advanced non-small cell lung cancer116 cited
  • 2017Dreamtime: Version 5.0 of the Australian Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (PBAC)99 cited
  • 2010

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

A Review and Meta-Analysis of Utility Values for Lung Cancer
78 cited
  • 2013Systematic Searching and Selection of Health State Utility Values from the Literature77 cited
  • 2010Derivation of Utility Values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 Questionnaire Values in Lung Cancer62 cited
  • Cited by

    No citing works inside the corpus for this window.